Portfolio Analysis: Conduct "Gap Analysis" to identify molecules losing patent protection and assist in the commercial launch of "Day-1" generics. Trade & Channel Marketing: Develop promotional schemes for pharmacies and hospital procurement heads to ensure our brand is the "preferred generic" at the point of sale. AI-Driven Market Intelligence: Use AI search and social listening tools to track competitor pricing and supply disruptions in real-time. Regulatory Liaison: Collaborate with Regulatory Affairs to ensure all marketing collateral (LBLs, brochures) complies with the 2026 updated GxP and local advertising codes. CME & Engagement: Organize "Continuing Medical Education" (CME) webinars for doctors to reinforce the bio-equivalence and safety of our generic versions. Digital Front Door Management: Optimize our digital presence so that when HCPs or pharmacists search for a molecule, our product is the top-recommended, high-quality alternative.
